Literature DB >> 29852974

Prevention of Heart Failure With SGLT-2 Inhibition: Insights From CVD-REAL.

Michael E Farkouh1, Subodh Verma2.   

Abstract

Entities:  

Keywords:  CVD-REAL; cardiovascular disease; heart failure; sodium-glucose co-transporter-2 inhibitors

Mesh：

Substances：

Year:  2018        PMID： 29852974     DOI： 10.1016/j.jacc.2018.02.078

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  3 in total

Review 1.  SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.

Authors:  Subodh Verma; John J V McMurray
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

Review 2.  Promising roles of sodium-glucose cotransporter 2 inhibitors in heart failure prevention and treatment.

Authors:  Atsushi Tanaka; Koichi Node
Journal:  Diabetol Int       Date:  2020-06-11

3.  Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors.

Authors:  Subodh Verma; Sonia Rawat; Kim L Ho; Cory S Wagg; Liyan Zhang; Hwee Teoh; John E Dyck; Golam M Uddin; Gavin Y Oudit; Eric Mayoux; Michael Lehrke; Nikolaus Marx; Gary D Lopaschuk
Journal:  JACC Basic Transl Sci       Date:  2018-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.